Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Arora

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Genitourinary Cancer|November 28, 2017
Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the ProstateAhmed Elshafei, Kae Jack Tay, Onder Kara, et al.
Urology|June 20, 2017
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active SurveillanceVishnu Ganesan, Charles Dai, Yaw A Nyame, et al.
The Journal of Urology|March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active SurveillanceYaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
The Journal of Urology|August 10, 2017
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable FeaturesCharles Dai, Vishnu Ganesan, Joseph Zabell, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Genitourinary Cancer|November 28, 2017
Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the ProstateAhmed Elshafei, Kae Jack Tay, Onder Kara, et al.
Urology|June 20, 2017
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active SurveillanceVishnu Ganesan, Charles Dai, Yaw A Nyame, et al.
The Journal of Urology|March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active SurveillanceYaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
The Journal of Urology|August 10, 2017
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable FeaturesCharles Dai, Vishnu Ganesan, Joseph Zabell, et al.
Pageof 2